UNIVERSITY OF ILLINOIS
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1859-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.illinois.edu
Lamotrigine Monotherapy in Pediatric Bipolar Disorder
- First Posted Date
- 2005-09-15
- Last Posted Date
- 2015-07-30
- Lead Sponsor
- University of Illinois at Chicago
- Target Recruit Count
- 48
- Registration Number
- NCT00176228
- Locations
- 🇺🇸
NPI, University of Illinois at Chicago, Chicago, Illinois, United States
Evaluation of a Youth Mentoring Program
- Conditions
- Interventions
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2020-05-14
- Lead Sponsor
- University of Illinois at Chicago
- Target Recruit Count
- 40
- Registration Number
- NCT00158353
- Locations
- 🇺🇸
University of Illinois at Chicago, Chicago, Illinois, United States
Effects of Risperdal Consta on Ability to Benefit From Social Skills Training in Schizophrenia
- Conditions
- First Posted Date
- 2005-09-07
- Last Posted Date
- 2019-05-15
- Lead Sponsor
- University of Illinois at Chicago
- Target Recruit Count
- 5
- Registration Number
- NCT00148083
- Locations
- 🇺🇸
University of Illinois at Chicago, Chicago, Illinois, United States
🇺🇸New York Presbyterian Hospital, White Plains, New York, United States
Lycopene in Preventing Prostate Cancer in Healthy Participants
- Conditions
- First Posted Date
- 2004-10-08
- Last Posted Date
- 2013-06-26
- Lead Sponsor
- University of Illinois at Chicago
- Registration Number
- NCT00093561
- Locations
- 🇺🇸
University of Illinois at Chicago Cancer Center, Chicago, Illinois, United States
Biological Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast Cancer
- Conditions
- First Posted Date
- 2004-08-31
- Last Posted Date
- 2013-09-20
- Lead Sponsor
- University of Illinois at Chicago
- Target Recruit Count
- 36
- Registration Number
- NCT00002616
- Locations
- 🇺🇸
University of Illinois at Chicago Health Sciences Center, Chicago, Illinois, United States
Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancer
- First Posted Date
- 2004-08-13
- Last Posted Date
- 2013-12-04
- Lead Sponsor
- University of Illinois at Chicago
- Target Recruit Count
- 46
- Registration Number
- NCT00003251
- Locations
- 🇺🇸
University of Illinois at Chicago Health Sciences Center, Chicago, Illinois, United States
Vaccine Therapy With High-Dose Interleukin-2 in Treating Patients With Metastatic Melanoma
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-06-26
- Lead Sponsor
- University of Illinois at Chicago
- Registration Number
- NCT00003568
- Locations
- 🇺🇸
City of Hope Comprehensive Cancer Center, Duarte, California, United States
🇺🇸Comprehensive Cancer Center at Our Lady of Mercy Medical CenterOur, Bronx, New York, United States
🇺🇸Loyola University Medical Center, Maywood, Illinois, United States
Lycopene In Preventing of Prostate Cancer
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-06-26
- Lead Sponsor
- University of Illinois at Chicago
- Registration Number
- NCT00006078
- Locations
- 🇺🇸
University of Illinois Medical Center, Chicago, Illinois, United States